当前位置:首页 - 行情中心 - 多瑞医药(301075) - 财务分析

多瑞医药

(301075)

  

流通市值:5.72亿  总市值:16.70亿
流通股本:2742.37万   总股本:8000.00万

多瑞医药(301075)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.18亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益82573.45万元,未分配利润16646.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产108239.97万元,负债25666.53万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入246,256,774.84170,393,701.0678,085,173.39401,049,788.47
营业总成本239,577,465.5163,038,293.8281,960,671.26388,452,256.83
营业利润20,138,145.5414,725,686.62-2,364,058.3321,256,288.87
利润总额20,420,961.6415,018,990.43-2,331,674.1921,024,834.99
净利润17,653,964.1413,407,483.1-2,520,711.1918,583,853.01
其他综合收益7,901,3857,901,3857,901,385-1,295,827.14
综合收益总额25,555,349.1421,308,868.15,380,673.8117,288,025.87
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计676,810,830.81666,950,662.51675,995,466.59647,426,048.56
非流动资产合计405,588,875.04287,108,082.96256,161,253.2251,442,635.73
资产总计1,082,399,705.85954,058,745.47932,156,719.79898,868,684.29
流动负债合计254,157,278.89178,742,929.39172,616,869144,571,942.4
非流动负债合计2,507,972.91665,713.59744,622.14955,507.5
负债合计256,665,251.8179,408,642.98173,361,491.14145,527,449.9
归属于母公司股东权益合计778,664,673.53773,720,220.39757,009,963.12751,452,486.5
股东权益合计825,734,454.05774,650,102.49758,795,228.65753,341,234.39
负债和股东权益合计1,082,399,705.85954,058,745.47932,156,719.79898,868,684.29
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计340,445,845.95211,665,034.24117,016,475.53491,064,417.33
经营活动现金流出小计316,279,234.73209,575,348.7999,343,306.56489,937,788.1
经营活动产生的现金流量净额24,166,611.222,089,685.4517,673,168.971,126,629.23
投资活动现金流入小计289,500,862.76147,419,899.2166,574,437.19425,881,915.71
投资活动现金流出小计380,075,450.25159,800,838157,342,578628,725,447.82
投资活动产生的现金流量净额-90,574,587.49-12,380,938.89,231,859.19-202,843,532.11
筹资活动现金流入小计120,099,520102,000,00050,000,000124,090,000
筹资活动现金流出小计51,316,763.6340,834,083.34461,25079,050,994.58
筹资活动产生的现金流量净额68,782,756.3761,165,916.6649,538,75045,039,005.42
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额2,374,780.150,874,663.3176,443,778.16-156,677,897.46
期末现金及现金等价物余额426,420,925.58476,639,537.54500,489,923.64324,092,686.18
TOP↑